0:00
11:00
@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.
Flere episoder fra "Healthspan"
Gå ikke glip af nogen episoder af “Healthspan” - abonnér på podcasten med gratisapp GetPodcast.